SOGIPHARMA financials
A multi-period view of the public annual-account figures reported for SOGIPHARMA, with comparable measures and links to available source documents.
Company overviewRegistry number
0440387324
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for SOGIPHARMA
2025 versus 2024
- Operating line
- €114,207
- EBITDA
- €108,088
- Total assets
- €1,425,015
- Equity
- €484,629
-5.8%
-2%
+33.8%
+0.3%
EBITDA margin +94.6% · Equity ratio +34%
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.